New-Generation Devices Aid Growth of Global ECG Devices Market
|
By HospiMedica International staff writers Posted on 22 Aug 2019 |
The global electrocardiography devices (ECG) market is projected to grow at a CAGR of over 6% over the forecast period 2019-2023, driven primarily by technological advances, which have helped in developing easy-to-use devices with reduced size and enhanced portability. The market growth is further aided by the increasing prevalence of cardiovascular disease (CVD) and their growing awareness. However, the high cost of EVG devices, increasing demand for refurbished ECG devices and lack of skilled clinicians with expertise in ECG could hamper the growth of the ECG market over the forecast period.
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
In addition to reduced size and enhanced portability, the new-generation ECG devices also incorporate advanced algorithms, which provide high-fidelity data to support better clinical decisions. Additionally, the latest ECG devices incorporate various workflow improvement features, such as simplified step-by-step operation, touch-screen systems, and better connectivity with ECG management systems. Moreover, technological advances in sensors now allow recording of electrical impulses from the heart in the absence of conventional ECG machines. Several technologies are now wearable and can monitor and record cardiac impulses for weeks or even months. These devices are increasingly being adopted in out-of-hospital settings such as households and public places. These developments are expected to have a positive impact on the growth of the global ECG market.
In 2018, the resting ECG devices segment held a significant share and is expected to continue dominating the global ECG market over the forecast period due to the increasing focus on early diagnosis and disease prevention, rising number of resting ECG procedures and technological advances.
Related Links:
Research and Markets
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
In addition to reduced size and enhanced portability, the new-generation ECG devices also incorporate advanced algorithms, which provide high-fidelity data to support better clinical decisions. Additionally, the latest ECG devices incorporate various workflow improvement features, such as simplified step-by-step operation, touch-screen systems, and better connectivity with ECG management systems. Moreover, technological advances in sensors now allow recording of electrical impulses from the heart in the absence of conventional ECG machines. Several technologies are now wearable and can monitor and record cardiac impulses for weeks or even months. These devices are increasingly being adopted in out-of-hospital settings such as households and public places. These developments are expected to have a positive impact on the growth of the global ECG market.
In 2018, the resting ECG devices segment held a significant share and is expected to continue dominating the global ECG market over the forecast period due to the increasing focus on early diagnosis and disease prevention, rising number of resting ECG procedures and technological advances.
Related Links:
Research and Markets
Latest Business News
- Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreCritical Care
view channel
FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
Obstructive sleep apnea is common but often underdiagnosed, partly because access to in-lab polysomnography is limited and wait times are long. Clinicians need home-based diagnostics that can reliably... Read more
Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
Out-of-hospital cardiac arrest is a sudden loss of heart function that often occurs without witnesses and demands immediate response. Delayed recognition and activation of emergency services reduce survival... Read moreSurgical Techniques
view channel
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel







